Epigenetics Interest Group
New! Join us for a lecture by Jonathan Weissman of the MIT Whitehead Institute on Wednesday, June 5, at 2:00 p.m. ET.
The talk is titled "Epigenome Editing as a Tool for Basic Discovery and Therapeutic Intervention." This will be in person at the Lipsett Amphitheater, Building 10, but also online (and then archived) via https://videocast.nih.gov/watch=52301.
---
Epigenetics represents a new frontier in cancer research. Information in the genome exists in at least two forms: genetic and epigenetic. The genetic information provides the blueprint for the manufacture of all the proteins necessary to create a living organism, whereas epigenetic information provides additional instructions on how, where, and when the genetic information will be used. The focus of the Epigenetics Interest Group is on applications of epigenetic approaches in disease detection, risk assessment, and treatment. The group organizes and disseminates information about epigenetics-related conferences, meetings, and webinars and meets in person when appropriate. Please contact Dr. Mukesh Verma (vermam@mail.nih.gov) at 240-276-6889 for more information.
Useful Resources
- International Human Epigenome Consortium (IHEC): https://ihec-epigenomes.org/welcome/
- Australasian Epigenomic Alliance: https://www.aepia.org.au/
- Epigenomics Common Fund: https://commonfund.nih.gov/epigenomics
- Clinical Trials in Epigenetics: https://clinicaltrials.gov/search (search for specific disease)
Chair
- Mukesh Verma, Ph.D., NCI
Advisor
- Mukesh Verma, Ph.D., NCI
Scientific Focus Areas
Genetics and Genomics
This page was last updated on Thursday, May 30, 2024